Unknown

Dataset Information

0

Advances in treating chronic lymphocytic leukemia.


ABSTRACT: Chronic lymphocytic leukemia (CLL) is the most prevalent type of leukemia, affects mostly elderly CLL patients, and is incurable without allogeneic transplantation. Although classic chemo(immuno)therapy is still the standard of care for patients in need of treatment, this paradigm might change in the near future with the advent of new therapeutic agents targeting major pathogenic pathways in CLL.

SUBMITTER: Tausch E 

PROVIDER: S-EPMC4126532 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Advances in treating chronic lymphocytic leukemia.

Tausch Eugen E   Mertens Daniel D   Stilgenbauer Stephan S  

F1000prime reports 20140801


Chronic lymphocytic leukemia (CLL) is the most prevalent type of leukemia, affects mostly elderly CLL patients, and is incurable without allogeneic transplantation. Although classic chemo(immuno)therapy is still the standard of care for patients in need of treatment, this paradigm might change in the near future with the advent of new therapeutic agents targeting major pathogenic pathways in CLL. ...[more]

Similar Datasets

| S-EPMC5664994 | biostudies-literature
| S-EPMC6707935 | biostudies-literature
| S-EPMC8996890 | biostudies-literature
| S-EPMC4831394 | biostudies-other
| S-EPMC2891437 | biostudies-literature
| S-EPMC8981798 | biostudies-literature
| S-EPMC9276188 | biostudies-literature
| S-EPMC9264813 | biostudies-literature
| S-EPMC3791640 | biostudies-literature
| S-EPMC4449150 | biostudies-other